Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry site by Bieleski, L & Talbot, Simon
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kaposi's sarcoma-associated herpesvirus vCyclin open reading
frame contains an internal ribosome entry site
Citation for published version:
Bieleski, L & Talbot, S 2001, 'Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame
contains an internal ribosome entry site' Journal of Virology, vol. 75, no. 4, pp. 1864-9. DOI:
10.1128/JVI.75.4.1864-1869.2001
Digital Object Identifier (DOI):
10.1128/JVI.75.4.1864-1869.2001
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Journal of Virology
Publisher Rights Statement:
Copyright © 2001, American Society for Microbiology. All Rights Reserved.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
JOURNAL OF VIROLOGY,
0022-538X/01/$04.0010 DOI: 10.1128/JVI.75.4.1864–1869.2001
Feb. 2001, p. 1864–1869 Vol. 75, No. 4
Copyright © 2001, American Society for Microbiology. All Rights Reserved.
Kaposi’s Sarcoma-Associated Herpesvirus vCyclin Open Reading
Frame Contains an Internal Ribosome Entry Site
LARA BIELESKI AND SIMON J. TALBOT*
Laboratory for Clinical and Molecular Virology, University of Edinburgh,
Edinburgh EH9 1QH, United Kingdom
Received 15 September 2000/Accepted 29 November 2000
We have previously examined the transcription and splicing of open reading frames (ORFS) 71 (K13), 72,
and 73 of Kaposi’s sarcoma-associated herpesvirus (KSHV) in the primary effusion lymphoma cell line BCP-1
(latently infected with KSHV) (45). The three genes encoded by these ORFs (for vFLIP, vCyclin, and latency-
associated nuclear antigen [LANA]) are transcribed from a common transcription start site in BCP-1 cells
during both latency and the lytic cycles. The resulting transcript is spliced to yield a 5.32-kb message encoding
LANA, vCyclin, and vFLIP and a 1.7-kb bicistronic message encoding vCyclin and vFLIP. To investigate
whether the vFLIP protein could be expressed from this vCyclin/vFLIP message, we utilized a bicistronic
luciferase reporter system. The genes for Renilla and firefly luciferases (which utilize different substrates) were
cloned in tandem downstream from a T7 RNA polymerase promoter. Fragments of DNA immediately upstream
from the initiating codon of vFLIP were cloned between the two luciferase genes. The relative expression of the
two luciferases, one directed by the putative internal ribosome entry site (IRES) sequences and the other by
cap-dependent ribosome scanning, was used to compare the activities of the different DNA fragments. A
minimum fragment of 233 bp within the coding region of vCyclin was found to direct efficient expression of the
downstream cistron (firefly luciferase). The activity of this IRES was orientation dependent and unaffected by
methods used to inhibit cap-dependent translation. This is the first demonstration of an IRES element encoded
by a DNA virus and may represent a novel mechanism through which KSHV controls protein expression.
Kaposi’s sarcoma (KS) is a vascular tumor occurring most
commonly in patients with AIDS (3, 4). KS lesions are histo-
logically complex and contain proliferating spindle-shaped
cells considered to be of endothelial origin, infiltrating mono-
nuclear cells, plasma cells, and abundant neovascular spaces
(7). The recently identified KS-associated herpesvirus (KSHV)
(10) is implicated in the etiology of all epidemiological
forms of KS, i.e., Mediterranean classic, African endemic,
posttransplant or iatrogenic, and the most commonly occurring
AIDS-associated form (8). KSHV sequences have also been
identified inseveral rare lymphomas, suchasmulticentricCastle-
man’s disease and primary effusion lymphoma (PEL), also
known as body cavity-based large-cell lymphoma (9, 42). The
seroprevalence of KSHV in the general population exhibits
variations with geographic distribution. Very low rates of prev-
alence have been reported for populations in Britain and
North America, whereas high rates prevail in Africa and south-
ern Europe (19, 31, 41). However, antibody kinetic studies
have shown that a strong correlation exists between conversion
to seropositivity and the risk for development of KS (19, 29).
Thus, KSHV has been proposed as the etiologic agent for KS
and other KSHV-associated malignancies.
KSHV is a gammaherpesvirus that is closely related to three
other herpesviruses with oncogenic potential: herpesvirus sai-
miri, the murine gammaherpesvirus (MHV-68) and, more dis-
tantly, Epstein-Barr virus (34, 38). The complete nucleotide
sequence of KSHV DNA has revealed several genes, which
were probably captured from the host cell during viral evolu-
tion and whose products could also play a role in cellular
transformation and tumor induction. These include a cyclin D
homolog (vCyclin) (11, 21), a Bcl-2 homolog (13), a viral
FLICE (FADD [Fas-associated death domain]-like interleu-
kin-1 beta-converting enzyme)-inhibitory protein (vFLIP) (17,
46), and a G-protein coupled receptor homolog (1).
The three genes encoded by open reading frames (ORFs)
71, 72, and 73 (for vFLIP, vCyclin, and latency-associated nu-
clear antigen [LANA]) are transcribed from a common tran-
scription start site in BCP-1 cells that are uninduced (latent) or
induced (lytic) with n-butyrate. The resulting transcript is
spliced to yield a 5.32-kb message encoding LANA, vCyclin,
vFLIP, and a 1.7-kb bicistronic message encoding vCyclin and
vFLIP (16, 45). Since a monocistronic transcript coding for
vFLIP alone has never been detected, some other unconven-
tional mechanism involving translational reinitiation, internal
ribosomal entry, or leaky ribosomal scanning may be impli-
cated in the expression of vFLIP.
All nuclear eukaryotic mRNAs possess a cap structure
(m7GpppN, where N is any nucleotide) at their 59 end. The cap
plays a central role in promoting ribosome binding to the
mRNA and controlling the rate of translation initiation (20,
40). Ribosomes can, however, access a eukaryotic mRNA by
binding to an internal ribosome entry site (IRES). IRESs were
first identified in picornavirus RNA, which does not have a 59
cap structure (27, 36), and have since been characterized in
other viruses, such as hepatitis C virus (47), and also in cellular
mRNAs involved in cell proliferation and apoptosis (fibroblast
growth factor-2 [48], vascular endothelial growth factor [43],
X-linked inhibitor of apoptosis [24], and the protooncogene
c-myc [33, 44]). Recently, IRES elements in two cellular mRNAs
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(encoding omithine decarboxylase [ODC] and PITSLRE protein
kinase) have been identified which are regulated in a cell-cycle-
dependent manner (15, 37). These data reveal a novel role for
IRES elements in the translational regulation of protein expres-
sion during cell cycle progression.
In this paper we describe the identification of an IRES
element within the KSHV cyclin ORF. This 233-nucleotide
sequence could direct the translation of the downstream vFLIP
ORF from the vCyclin/vFLIP bicistronic transcript.
MATERIALS AND METHODS
Cells. The KSHV-positive PEL B-cell line, BCP-1 (6), was grown in RPMI
(Gibco) supplemented with 20% (vol/vol) fetal calf serum (FCS), 2 mM glu-
tamine, 60 mg of penicillin/ml, and 100 mg of streptomycin/ml. The endothelial
cell line KS-IMM, derived from a KS lesion (2), was grown in MCDB131 media
(Gibco) supplemented with 10% (vol/vol) FCS, 10 mM glutamine, 20 ng of
endothelial cell growth supplement (Sigma)/ml, 60 mg of penicillin/ml, and 100
mg of streptomycin/ml. HEK293 cells (22) were grown in Dulbecco’s modified
Eagle’s medium (Gibco) supplemented with 10% (vol/vol) FCS, 2 mM glu-
tamine, 60 mg of penicillin/ml, and 100 mg of streptomycin/ml. Cells were incu-
bated at 37°C under 4% CO2.
Plasmids. The plasmid pdLUC was constructed by cloning the firefly luciferase
gene (from pGL3-basic; Promega) as an NheI-XbaI fragment downstream of the
Renilla luciferase gene at the XbaI site in the plasmid pRL-CMV (Promega).
Plasmid pdLUC-SL is identical to pdLUC except for a 60-nucleotide sequence
(59GCTAGCGGTACGGCAGTGCCGTACGACGAATTCGTCGTACGGC
ACTGCCGTACCGCTAGC39), capable of forming a stable 28-bp stem-loop
(DG 5 262 kcal/mol), cloned at the NheI site immediately upstream from the
Renilla luciferase start codon (see Fig. 1b).
The IRES sequence from encephalomyocarditis virus (EMCV) or fragments
of KSHV vCyclin/vFLIP were cloned into the SmaI-NcoI sites of pdLUC and
pdLUC-SL.
Transfection of cells. BCP-1 cells (105 cells per well), HEK293 (5 3 104 cells
per well), or KS-IMM (5 3 104 cells per well) were seeded in 24-well trays and
incubated overnight. The cells were infected with vTF7-3 (18), a recombinant
vaccinia virus expressing T7 RNA polymerase, at 5 PFU per cell in 200 ml of
serum-free medium (OptiMEM; Gibco-BRL) for 60 min at 37°C. The inoculum
was removed, and the cells were washed once with OptiMEM. The cells were
then transfected with 0.5 mg of linearized (AflII and NotI) plasmid DNA and 1.5
ml of Transfast transfection reagent per well according to the instructions of the
manufacturer (Promega). Following a 1-h incubation at 37°C, 1 ml of growth
medium was added to the wells. The cells were assayed for luciferase activity 24 h
later as described below.
Dual luciferase assays. Transfected cells were washed twice in phosphate-
buffered saline and then lysed by addition of 200 ml of passive lysis buffer
(Promega). After incubation for 15 min at room temperature, the cell lysates
were transferred to Eppendorf tubes and snap frozen on dry ice. The lysates were
then thawed and vortexed for 1 min, and the cell debris was removed by spinning
at 10,000 3 g for 1 min. The activities of Renilla and firefly luciferases were
assayed using the dual luciferase system as described by the manufacturer (Pro-
mega). Luciferase activities were measured using a Labsystems benchtop lumi-
nometer, and the ratio of firefly luciferase activity to Renilla luciferase activity
was calculated and used as a measure of IRES function.
Northern blots. BCP-1 cells (2 3 106) were infected with vaccinia vTF7-3 (18)
(multiplicity of infection 5 5) and then transfected with 2 mg of linearized
plasmid DNA as described above. Twenty-four hours posttransfection, Poly(A)1
RNA was isolated (Sigma) from the BCP-1 cells. The mRNA (equivalent to 106
cells per lane) was separated on formaldehyde agarose gels as described previ-
ously (39) and transferred onto a Genescreen-plus membrane by capillary blot-
ting according to the manufacturer’s instructions (NEN Research products). The
filters were baked at 80°C for 2 h and then hybridized to Renilla or firefly
luciferase DNA probes randomly labeled with [a-32P]dCTP. Filters were prehy-
bridized for 20 min and hybridized for 60 min at 60°C in QuickHyb solution
(Stratagene). Blots were washed twice for 15 min at 20°C in 23 SSC (13 SSC is
0.15 M NaCl plus 0.015 M sodium citrate)–0.1% (wt/vol) sodium dodecyl sulfate
and once for 30 min at 60°C in 0.13 SSC–0.1% sodium dodecyl sulfate before
exposure to X-ray film (X-OMAT-AR-Kodak) at 280°C with an intensifying
screen.
RESULTS
The major latently expressed loci within the KSHV genome
contain three genes: those for LANA, vCyclin (Cyclin D ho-
molog), and vFLIP (Flice inhibitory protein homolog) (30).
Two mRNA transcripts from this region are seen in cells la-
tently infected with KSHV. Both are transcribed from a com-
mon transcription start site and are differentially spliced
to yield a tricistronic message encoding LANA, vCyclin, and
vFLIP and a bicistronic message encoding vCyclin and vFLIP
(Fig. 1a) (16, 45). There have been no reports of further splic-
ing events resulting in a monocistronic transcript encoding for
vFLIP alone, suggesting that this ORF may be translated via an
unconventional mechanism. To test the hypothesis that this
bicistronic transcript could contain an IRES allowing the trans-
lation of the downstream vFLIP ORF, we constructed a bicis-
tronic luciferase reporter plasmid (pdLUC) (Fig. 1b). In this
plasmid the downstream cistron (firefly luciferase) would or-
dinarily be accessed inefficiently by ribosomes which have com-
pleted translation of the upstream cistron (Renilla luciferase).
However, if an IRES sequence (e.g., EMCV IRES) (Fig. 2a) is
inserted before the downstream ORF, translation is consider-
FIG. 1. (a) Map of the left end of the KSHV genome showing the
transcription of the latent genes ORF 71, 72, and 73 encoding vFLIP,
vCyclin, and LANA, respectively. Two spliced transcripts are observed
in PEL cell lines: one tricistronic transcript encoding LANA, vCyclin,
and vFLIP and one bicistronic transcript encoding vCyclin and vFLIP.
(b) Schematic diagram of the plasmids pdLUC and pdLUC-SL. Both
plasmids have the coding sequence for the Renilla and firefly luciferase
enzymes cloned downstream of a T7 RNA polymerase promoter. The
plasmid pdLUC-SL has a stable 28-bp stem-loop cloned immediately
upstream of the Renilla luciferase start codon.
VOL. 75, 2001 KSHV vCYCLIN ORF CONTAINS AN IRES 1865
ably enhanced (up to 100-fold). This system offers the advan-
tage that both reporter enzymes can be assayed in the same cell
lysate preparation, with the activity of the two luciferase en-
zymes (which utilize different substrates) determined using a
benchtop luminometer. In addition, the upstream reporter
(Renilla luciferase) acts as an internal control to account for
differences in transfection efficiency. The plasmids were con-
structed such that transcription of the bicistronic reporter was
driven from a T7 RNA polymerase promoter. The constructs
were transfected into cells infected with a recombinant vac-
cinia virus (vTF7-3) (18) which expresses T7 RNA polymerase,
therefore allowing cytoplasmic transcription of the bicistronic
mRNAs. Since this system bypasses the nuclear transcription
pathway, the possibility of splicing accounting for expression of
the downstream cistron is eliminated.
The KSHV vCyclin coding sequence contains an IRES ele-
ment. Restriction enzyme fragments of the vCyclin coding se-
quence immediately upstream from the vFLIP start codon
were cloned into the pdLUC plasmid as shown in Fig. 2a.
These plasmids were transfected into the BCP-1 cell line (la-
tently infected with KSHV), which had been infected with
vaccinia virus vTF7-3 (18) at a multiplicity of infection of 5.
The Renilla luciferase and firefly luciferase activities were mea-
sured in cell lysates 24 h posttransfection. The ratio of firefly
luciferase activity to Renilla luciferase activity was calculated
and used as a measure of IRES function. These data (Fig.
2a) show that a 233-nucleotide sequence between the SacII
and Eco47III restriction sites (nucleotides 123206 to 122973;
GenBank accession no. U75698) (38) in the vCyclin coding
sequence is capable of directing efficient translation of the
firefly luciferase. Reducing the size of this fragment further
using the AatII restriction site resulted in a complete loss of
IRES activity. Although this putative IRES sequence was less
efficient (10.6 versus 30%) than the well-characterized IRES
from EMCV, it still promoted translation well above back-
ground levels. We also note that the expression of firefly lucif-
erase from pdLuc8 (SacII-Eco47III) was more efficient (10.6
versus 6.2%) than that from pdLuc3 (SacII-NcoI) (Fig. 2a).
This may reflect the smaller nucleotide distance from the IRES
element to the downstream cistron, or alternatively, the in-
creased activity could be due to the removal of two start co-
dons that could potentially compete for scanning ribosomes.
The function of this vCyclin IRES was orientation dependent
(Fig. 2a).
A Northern blot analysis of poly(A)1 RNA isolated from
BCP-1 cells infected with vaccinia vTF7-3 (18) and transfected
with pdLuc, pdLuc-EMCV, or pdLuc8 and probed with firefly
luciferase DNA showed that the cells expressed bicistronic
mRNA of the predicted size (Fig. 3). We did not observe any
smaller transcripts representing alternative transcription start
sites within the KSHV sequences, even on overexposed blots
(data not shown). These data suggest that the enhanced ex-
pression of the downstream firefly luciferase gene resulted
from IRES-driven translation rather than from unusual splic-
ing events, RNA fragmentation, or a cryptic vaccinia virus pro-
moter.
The function of the vCyclin IRES element was also tested in
both HEK293 (22) and KSIMM cells (2) (a KSHV-negative
endothelial cell line derived from a KS biopsy). Although the
EMCV IRES directed efficient translation of the second cis-
FIG. 2. Assay for IRES activity in BCP-1 cells. The indicated re-
striction fragments from the vCyclin gene were cloned between the
SmaI and NcoI sites of pdLUC (a) or pdLUC-SL (b). The activities of
firefly (FF) and Renilla (RL) luciferase (in relative light units) and the
ratio (%) of the two from a representative experiment are shown. The
restriction sites shown on the schematic diagram of vCyclin and vFLIP
are as follows: NcoI, BamHI, SacII, AatII, Eco47III, PvuII, HindIII,
NcoI.
FIG. 3. Northern blot of poly(A)1 RNA purified from BCP-1 cells
infected with vaccinia vTF73 (18) and transfected with pdLUC (lane
1), pdLUC-EMCV (lane 2), or pdLUC-8 (lane 3) or untransfected
(lane 4). The blot was probed with DNA corresponding to the firefly
luciferase gene. The approximate size predicted for each transcript is
2.7 kb (pdLUC), 3.3 kb (pdLUC-EMCV), or 2.9 kb (pdLUC-8). Size
markers (kb) are indicated.
1866 BIELESKI AND TALBOT J. VIROL.
tron in these cells, none of the vCyclin sequences appeared to
function as an IRES (Table 1). These data suggest that specific
KSHV or cellular factors may be required for efficient func-
tioning of the vCyclin IRES.
Inhibition of translation of the upstream cistron does not
affect the activity of the IRES. To show that the enhanced
expression of the firefly luciferase cistron was due to an IRES
sequence within the vCyclin gene and was not dependent on
the translation of the upstream Renilla luciferase cistron, we
constructed a plasmid that inhibited translation of the first
cistron. This was achieved by using an equivalent reporter
construct (pdLUC-SL; Fig. 1b) that contained an inverted re-
peat, with the potential to form a stable 28-bp stem-loop struc-
ture in the 59 untranslated region (UTR) immediately up-
stream from the Renilla luciferase start codon. The data shown
in Fig. 2b show that translation of the first cistron is efficiently
inhibited by the presence of the stable stem-loop structure.
However, translation of the second cistron via the IRES se-
quence within the vCyclin gene was unaffected by the presence
of the stem-loop. This confirms that translation of the second
cistron is dependent not on translation of the first cistron but
rather on the presence of specific sequence elements within the
IRES sequence.
The predicted RNA secondary structure of the vCyclin
IRES. An RNA secondary model was determined for the min-
imum vCyclin IRES sequence. The program RNA mfold (32,
49) was used to produce a structure with the lowest free energy
(DG 5 261.4 kcal/mol), as shown in Fig. 4. The model predicts
that this RNA sequence folds into two stable stem-loop struc-
tures separated by a short non-base-paired region. Sequence
comparisons revealed a stretch of 11 nucleotides that is 100%
complementary to a sequence in 18S rRNA (nucleotides 1150
to 1160). The secondary structure model predicts that this
sequence is in a single-stranded loop and therefore has the
potential for base-pairing interactions with 18S rRNA. A re-
cent report (12) described an IRES element within the 59 UTR
of the mRNA encoding the homeodomain protein Gtx, which
contained a nine-nucleotide segment 100% complementary to
18S rRNA (nucleotides 1124 to 1132). This 9-nucleotide frag-
ment still functioned as an IRES even when taken out of the
context of the rest of the 59 UTR, suggesting that this IRES
functioned at least in part via base-pairing between rRNA and
the mRNA. To test if this was also the case for the vCyclin
IRES, we cloned the 11-nucleotide sequence into the pdLUC
and pdLUC-SL reporter plasmids. However, this sequence was
unable to promote the translation of the second luciferase
cistron on its own (data not shown). Although these data do
not rule out the possibility of direct base pairing between the
IRES sequence and 18S rRNA, there must be additional ele-
ments within the vCyclin IRES that are necessary for its cor-
rect function. One such element could be the polypyrimidine-
rich sequence found at nucleotides 123199 to 123183. The
presence of polypyrimidine-rich sequences in several other
IRES elements in viruses and cellular mRNAs has been noted
(37). The fact that IRES activity is lost when the two stem-loop
structures are separated at the AatII site suggests that multiple
structural and sequence elements are essential for correct
function of the vCyclin IRES.
TABLE 1. IRES activity in HEK293 cells and KSIMM cellsa
Cell line Plasmid
Activity
RL FF FF:RL (%)
HEK293 pdLuc 4,122 6 1.4
pdLuc-EMCV 4,122 731 18
pdLuc8 5,595 5 0.9
KSIMM pdLuc 1,969 4 0.2
pdLuc-EMCV 1,194 299 25
pdLuc8 1,120 8 0.7
a The activities of firefly (FF) and Renilla (RL) luciferases (in relative light
units) and the ratio (%) of the two from a representative experiment are shown.
The structures of the plasmids are as shown in Fig. 2.
FIG. 4. Predicted secondary structure of the shortest functional
vCyclin IRES. The sequence between the SacII and Eco47III sites
(nucleotides 123206 to 122973; GenBank accession no. U75698) (38) is
shown in upper case. Vector sequences are shown in lower case. The
stop codon for the Renilla luciferase gene and the start codon for the
firefly luciferase gene are underlined. The 11-nucleotide sequence
complementary to 18S rRNA (nucleotides 1150 to 1160) is boxed, and
the polypyrimidine-rich sequence is shown in bold. The arrow shows
the cleavage position of the AatII site. The RNA was folded using
RNA mfold version 3.0 (32, 49). DG 5 261.4 kcal/mol.
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DISCUSSION
Analysis of KSHV gene expression has revealed a cluster
of latently expressed transcripts encoding LANA (ORF 73),
vCyclin (ORF 72), and vFLIP (ORF K13). The vCyclin and
vFLIP coding sequences are present on a bicistronic transcript
(30, 45). We have identified an IRES within the vCyclin coding
sequence (nucleotides 123206 to 122973) (38) that has the
potential to direct the translation of vFLIP from this bicis-
tronic transcript. IRES elements were first identified in the 59
UTR of picornaviruses (27, 36) and are essential for the cap-
independent translation of the viral polyprotein. More re-
cently, IRES elements have been characterized for several
cellular genes (14, 15, 23, 24, 28, 33, 37, 44).
It is unusual to find an IRES driving the translation of a gene
within the coding sequence of an upstream cistron (vCyclin).
Most IRESs examined to date are located within 59 UTR of
mRNAs. Although we have not yet formally shown that this
IRES actually controls the expression of vFLIP in vivo, we
assume that the data presented here using a dual luciferase
reporter system will parallel the situation in KSHV-infected
cells.
The KSHV cyclin complexed with cyclin-dependent kinase-6
(cdk6) has been shown to inactivate the retinoblastoma (Rb)
protein and thereby promote cell cycle progression and prolif-
eration (11, 21). It has been demonstrated that ectopic expres-
sion of vCyclin in cells with elevated levels of cdk6 leads to
apoptotic cell death after the cells enter S phase. Studies on
the mechanisms involved in this caspase-3-mediated apoptosis
indicated that it was independent of cellular p53 or pRb status,
and it was not suppressed by Bcl-2. In contrast, the KSHV-
encoded v-Bcl-2 efficiently suppressed vCyclin-/cdk6-induced
apoptosis (35). Abnormally proliferating cells are also known
to be a target for cytotoxic T-cell (CTL)-mediated cell killing
through FasL or tumor necrosis factor death receptors. Cellu-
lar FLIP (cFLIP) and KSHV vFLIP have been shown to inhibit
FasL-mediated apoptosis by binding to and blocking the death-
effector domain on the cytoplasmic C terminus of the Fas
receptor (CD95) (26, 35, 46). KSHV vFLIP protects cells from
Fas-mediated apoptosis by inhibiting caspase activation and
permits clonal growth in the presence of death stimuli in vitro.
KSHV vFLIP also mediates a tumor-progressive activity by
prevention of death receptor-induced apoptosis triggered by
CTLs in vivo (17). It therefore seems likely that the function of
vFLIP is to prevent CTL-mediated killing of proliferating cells
infected with KSHV, and this may explain why the expression
of vFLIP is so intimately linked to the expression of vCyclin.
Correct progression of the cell cycle requires that certain
proteins be present or active at specific times. It has been
shown that cells arrested in G2/M phase or in mitosis translate
mRNAs at about 25% of the rate of interphase cells. This is in
part due to an inhibition of the translation initiation step
due to a loss of the cap binding protein’s ability to bind the
59 m7GpppN cap structure present on eukaryotic mRNAs (5).
This results in a general loss of cap-dependent translation in
this phase of the cell cycle (5, 25). Recently, two reports (15,
37) have shown that two cellular mRNAs encoding ODC and
PITSLRE protein kinase are expressed from IRES elements
specifically during the G2/M phase of the cell cycle. These
mRNAs bypass the general inhibition of cap-dependent trans-
lation in G2/M-arrested cells by utilizing a cap-independent
IRES during this period of the cell cycle. These data may have
parallels with the expression of KSHV vCyclin and vFLIP. If
vFLIP is to protect KSHV-infected cells from CTL-mediated
apoptosis, then the levels of this inhibitor of FasL-mediated
apoptosis must remain at an appropriate level throughout the
cell cycle. One way of achieving this would be to ensure that
vFLIP is expressed via an IRES which is not susceptible to
cap-dependent inhibition of translation at G2/M.
It has been previously noted that the few eukaryotic mRNAs
that possess IRESs encode growth factors (fibroblast growth
factor 2 and vascular endothelial growth factor), oncogenes
(c-myc and ODC), and an inhibitor of apoptosis (XIAP) (37).
IRES-dependent translation of these mRNAs may be essential
for the survival and proliferation of cells under stressful con-
ditions. In this paper we have identified an IRES which poten-
tially controls the expression of a virally encoded anti apoptotic
protein, vFLIP, that is intimately linked to the expression of a
cell growth-promoting protein, vCyclin. Therefore, it is con-
ceivable that the expression of vFLIP from an IRES represents
a novel mechanism whereby KSHV ensures continued protec-
tion against CTL-induced apoptosis throughout the cell cycle.
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